New studies of the treatment of neuropathic pain have increased the need for an updated
review of randomized, double-blind, placebo-controlled trials to support an evidence based …

Tricyclic antidepressants and carbamazepine have become the mainstay in the treatment of
neuropathic pain. Within the last decade, controlled trials have shown that numerous other …

A longitudinal cohort study of 100 people with traumatic spinal cord injury (SCI) was
performed to determine the prevalence and severity of different types of pain …

Neuropathic pain treatment remains unsatisfactory despite a substantial increase in the
number of trials. This EFNS Task Force aimed at evaluating the existing evidence about the …

Chronic pain is an important problem following spinal cord injury (SCI) and is a major
impediment to effective rehabilitation. The reported prevalence of chronic SCI pain is …

The effectiveness of systemic lidocaine in relieving acute and chronic pain has been
recognized for over 35 years. In particular, systemic lidocaine has been utilized both as a …

Spinal cord injury (SCI) is an injury to the spinal cord that leads to varying degrees of motor
and/or sensory deficits and paralysis. Chronic pain of both neuropathic and nociceptive type …

Background Lidocaine, mexiletine, tocainide, and flecainide are local anesthetics which give
an analgesic effect when administered orally or parenterally. Early reports described the use …

Objective: To investigate the effects of systemic administration of lidocaine on different
components of neuropathic central pains by quantitative sensory testing. Methods: The …

Teasell RW, Mehta S, Aubut JL, Foulon B, Wolfe DL, Hsieh JTC, Townson AF, Short C, the
Spinal Cord Injury Rehabilitation Evidence Research Team. A systematic review of …